BIOSENSE WEBSTER INC CARTO VIZIGO¿ 8.5F BI-DIRECTIONAL GUIDING SHEATH ¿ SMALL; INTRODUCER, CATHETER
|
Back to Search Results |
|
Catalog Number D138501 |
Device Problems
Partial Blockage (1065); Contamination /Decontamination Problem (2895)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 11/03/2023 |
Event Type
malfunction
|
Manufacturer Narrative
|
This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster inc., or its employees that the report constitutes an admission that the product, biosense webster inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
|
|
Event Description
|
It was reported that a patient underwent an atrial fibrillation (afib) ablation procedure with a carto vizigo¿ 8.5f bi-directional guiding sheath ¿ small there was some accumulation at the hub and they couldn't flush it out.It was reported by the bwi reprsentative that during the case after they had inserted the carto vizigo¿ 8.5f bi-directional guiding sheath ¿ small into the patient's body they tried to flush, however, they noticed there was some accumulation at the hub and they couldn't flush it out.To troubleshoot the caller replaced the carto vizigo¿ 8.5f bi-directional guiding sheath ¿ small and continued with the case.There was no patient consequence.
|
|
Manufacturer Narrative
|
On 21-nov-2023, additional information was received indicating the accumulation at the hub was an accumulation of liquid but there was no leakage.The irrigation was significantly blocked and fluid was not coming out.There was a ¿clear plastic¿ causing the obstruction.There was no resistance reported and they were doing manual flushing.On 30-nov-2023, the bwi product analysis lab received the complaint device for evaluation.The product analysis has begun but is not completed at this time.When the investigational analysis has been completed, a supplemental 3500a report will be submitted.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
|
|
Manufacturer Narrative
|
It was reported that a patient underwent an atrial fibrillation (afib) ablation procedure with a carto vizigo¿ 8.5f bi-directional guiding sheath ¿ small there was some accumulation at the hub and they couldn't flush it out.It was reported by the bwi reprsentative that during the case after they had inserted the carto vizigo¿ 8.5f bi-directional guiding sheath ¿ small into the patient's body they tried to flush, however, they noticed there was some accumulation at the hub and they couldn't flush it out.To troubleshoot the caller replaced the carto vizigo¿ 8.5f bi-directional guiding sheath ¿ small and continued with the case.There was no patient consequence.Device evaluation details: the device was returned to biosense webster inc (bwi) for evaluation and the evaluation has been completed.Visual inspection and patency test of the returned device were performed following bwi procedures.Visual analysis revealed that no obstructions were observed in the hub area.A patency test was performed, and the device was flushing correctly, no obstructed holes were observed.No irrigation issues were observed.A device history record was performed for the finished device batch number, and no internal actions were identified.The issue reported by the customer could not be replicated during the product investigation; other issues or circumstances may have occurred during the usage of the device that compromised its performance.As part of biosense webster¿s quality process, all devices are manufactured, inspected, and released to approved specifications.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
|
|
Search Alerts/Recalls
|
|
|